| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/04/2001 | CN1301736A New polypeptide-gap ligandin 9 and polynucleotide coding sach polypeptide |
| 07/04/2001 | CN1301735A New polypeptide-amidase family protein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301734A New polypeptide-calcium ion binding protein 18 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301733A New polypeptide-fibrinogen 9 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301732A New polypeptide-thiolase protein 11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301731A New polypeptide-polyisoprene synthetase protein 9 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301730A New polypeptide-anion exchange protein 9 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301729A New polypeptide-corticotropin-releasing factor 13 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301728A New polypeptide-RCCI protein 11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301727A New polypeptide-PEP utilizing protein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301726A New polypeptide-rhodopsin arrestin family 11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301725A New polypeptide-ribosome protein S10 14 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301724A New polypeptide-signal identifying particle protein 8 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301723A New polypeptide-fibre binding protein pattern II10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301722A New polypeptide-heparin binding protein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301721A New polypeptide-photosensitive pigment 10 and polynucleotide codign such polypeptide |
| 07/04/2001 | CN1301720A New polypeptide-anion exchange protein 9 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301719A New polypeptide-ferritin 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301718A New polypeptide-cobalamin binding protein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301717A New polypeptide-gitter protein light chain 12 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301716A New polypeptide-phosphoribosyl pyrophosphoric synthetase protein 11 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301713A New polypeptide-stathmin-protein 8 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301712A New polypeptide-Ras GTP enzyme activated protein 12 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301710A New polypeptide-chromo structural domain-containing protein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301709A New polypeptide-small hydrophilic vegetable seed protein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301708A New polypeptide-po protein 9 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301707A Novel polypeptide-phosphoryl transport protein 10 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301706A Novel polypeptide-gap ligandin 14 and polynucleotide coding such polypeptide |
| 07/04/2001 | CN1301570A Use of nerve growth factor in curing organic solvent toxic peripheral neuropathy |
| 07/03/2001 | USH1973 Human neutrophil collagenase splice variant |
| 07/03/2001 | US6255474 Nucleotide sequences coding immunosuppressant for use in organ grafting |
| 07/03/2001 | US6255472 Isolated nucleic acid molecule encoding a human skeletal muscle-specific receptor |
| 07/03/2001 | US6255471 CRFG-1b, a target and marker for chronic renal failure |
| 07/03/2001 | US6255470 Isolated nucleic acid molecule encoding an esophageal cancer associated antigen |
| 07/03/2001 | US6255468 MPROT12 polynucleotides and methods thereof |
| 07/03/2001 | US6255467 Human blood bacterium |
| 07/03/2001 | US6255464 Mad-related genes in the human |
| 07/03/2001 | US6255461 Immunoglobulin; for use as a diagnostic and therapeutic tool in the treatment of mammalian defects |
| 07/03/2001 | US6255458 High affinity human antibodies and human antibodies against digoxin |
| 07/03/2001 | US6255457 Immunoglobulin for use as diagnositic tool and in preferential drug delivery |
| 07/03/2001 | US6255456 Enzymatic polypeptide; for use in diagnosis, detection, prevention and treatment of cancer and immune defects |
| 07/03/2001 | US6255454 Expression and use of human fibroblast growth factor receptor |
| 07/03/2001 | US6255453 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 07/03/2001 | US6255452 Protein associated with the suppression of celular proliferation; for use in gene therapy |
| 07/03/2001 | US6255354 Preparation of a pulmonary surfactant for instillation and oral application |
| 07/03/2001 | US6255348 Use of aminoadamantane compounds as immunoregulators |
| 07/03/2001 | US6255289 Gene delivery by secretory gland expression |
| 07/03/2001 | US6255286 Depsipeptides and drugs containing the same as the active ingredient |
| 07/03/2001 | US6255285 Phenethylamine derivatives |
| 07/03/2001 | US6255284 Pharmaceutical composition |
| 07/03/2001 | US6255283 Use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (TNF) |
| 07/03/2001 | US6255282 Lytic peptides |
| 07/03/2001 | US6255281 Complexing uteroglobin to fibronectin |
| 07/03/2001 | US6255280 Administering cyclosporin a dosage |
| 07/03/2001 | US6255279 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action |
| 07/03/2001 | US6255278 Concurrent with antigen administering |
| 07/03/2001 | US6255277 Localized use of nitric oxide-adducts to prevent internal tissue damage |
| 07/03/2001 | US6255113 Targeting an exogenous polynucleotide or complementary polynucleotide pair to an endogenous dna target in eukaryotic cells by homologous recombination; genetic disease therapy; sickle cell anemia, thalassemias and genetic cancers |
| 07/03/2001 | US6255111 A nucleic acid molecule targeting a molecule encoding a epidermal growth factor tyrosine kinase receptor; diagnosis and therapy diseases; antiproliferative and anticarcinogenic agents |
| 07/03/2001 | US6255105 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/03/2001 | US6255104 A recombinant vector containing an rna polymerase promoter linked to a mutant polio virus nucleic acid sequence, where the coat protein is deleted; gene therapy, antitumor agents, treating autoimmune diseases and human immunodefiecency virus |
| 07/03/2001 | US6255100 Cyclosporin fermentation process |
| 07/03/2001 | US6255096 An isolated nucleic acid encoding an amino acid; diagnosis and therapy for progressive mental retardation in conjuction with skeletal deformities |
| 07/03/2001 | US6255080 Proteinaceous antibiotic produce by microorganism; for use as silage agent or inoculant; for use as microbiocide; for amplified feed efficiency, reduced methane production, and reduced amounts of saturated fatty acids in dairy products |
| 07/03/2001 | US6255079 Polynucleotides encoding natural killer cell enhancing factor C |
| 07/03/2001 | US6255077 Human DNA topoisomerase I α |
| 07/03/2001 | US6255075 Nucleotide sequences coding biotin holoenzyme synthetase; for the prevention and treatment of bacterial infection |
| 07/03/2001 | US6255073 Cell segment from drosophila; for the treatment of cancer, tumors, viral or retroviral infection and autoimmune diseases |
| 07/03/2001 | US6255072 Nucleotide sequences coding proteolytic polypeptide; for use as diagnostic tool; for the prevention of bacterial infection |
| 07/03/2001 | US6255068 Protein ligand; for use in the amplification of cell viability |
| 07/03/2001 | US6255064 Disintegrin metalloprotease and its use |
| 07/03/2001 | US6255046 Drug screening of enzyme inhibitors by expressing enzyme or kinase domain, purifying, isolating, adding test compound and fructose 6-phosphate, and measuring formation of fructose 2,6 bisphosphate product; reduction indicates candidate |
| 07/03/2001 | US6254885 Containing: cyclosporin, ethanol or propylene glycol, non-ionic polyoxyalkylene surfactant, cosolvent; high bioavailability, used in immuno-suppressive therapy |
| 07/03/2001 | US6254884 Somatotropin compositions mixed with vitamins |
| 07/03/2001 | US6254870 Amino acid sequences |
| 07/03/2001 | US6254868 Monoclonal antibodies |
| 07/03/2001 | US6254867 Human monoclonal antibodies to the hepatitis B surface antigen |
| 07/03/2001 | US6254866 Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract |
| 07/03/2001 | US6254865 Method of treating huntington's disease using HNT neurons |
| 07/03/2001 | US6254862 Replication-competent adenovirus vectors |
| 07/03/2001 | US6254861 Hematopoietic growth factor derived from T lymphocytes |
| 07/03/2001 | US6254860 Ocular treatment using cyclosporin-A derivatives |
| 07/03/2001 | US6254856 Dextrinase from paecilomyces and a mutanase derived from trichoderma with ph from 6-8 |
| 07/03/2001 | US6254585 Surgical irrigation solution and method for inhibition of pain and inflammation |
| 07/03/2001 | CA2291144C Topical treatment of psoriasis using neutralizing antibodies to il-8 |
| 07/03/2001 | CA2198580C Combination therapy to treat osteoporosis |
| 07/03/2001 | CA2185568C Chlamydia vaccines and process |
| 07/03/2001 | CA2132512C Bioadhesive pharmaceutical composition used for the controlled release of active ingredient |
| 07/03/2001 | CA2116348C Sirs vaccine and diagnosis method |
| 07/03/2001 | CA2078773C Gp75 as a tumor vaccine for melanoma |
| 07/03/2001 | CA2075901C Tissue plasminogen activator having fibrin specific properties |
| 07/03/2001 | CA2012993C Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 07/03/2001 | CA2012115C Iodinated somatostatins |
| 06/28/2001 | WO2001046475A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046473A1 Treatment of mycobacterium tuberculosis with antisense polynucleotides |
| 06/28/2001 | WO2001046455A2 Survivin promotion of angiogenesis |
| 06/28/2001 | WO2001046454A1 P2y12 receptor |
| 06/28/2001 | WO2001046449A1 Replication incompetent herpes viruses for use in gene therapy |
| 06/28/2001 | WO2001046448A1 Inhibition of cellular proteases |
| 06/28/2001 | WO2001046443A2 Proteases |